Yeling Ruan
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Erratum: cDCBLD2 mediates sorafenib resistance in hepatocellular carcinoma by sponging miR-345-5p binding to the TOP2A coding sequence: Erratum.
Journal: International journal of biological sciences
Published: July 03, 2025
circRNA-SORE/UBQLN1/GPX4 Mediates the Acquisition of Sorafenib Resistance in Hepatocellular Carcinoma Through Inhibition of Ferroptosis.
Journal: MedComm
Published: June 30, 2024
Signaling pathways in liver cancer: pathogenesis and targeted therapy.
Journal: Molecular biomedicine
Published: January 04, 2024
S100A6 drives lymphatic metastasis of liver cancer via activation of the RAGE/NF-kB/VEGF-D pathway.
Journal: Cancer letters
Published: October 07, 2023
Circ-RAPGEF5 promotes intrahepatic cholangiocarcinoma progression by stabilizing SAE1 to facilitate SUMOylation.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 17, 2023
cDCBLD2 mediates sorafenib resistance in hepatocellular carcinoma by sponging miR-345-5p binding to the TOP2A coding sequence.
Journal: International journal of biological sciences
Published: May 16, 2023
Bulk and single-cell transcriptome profiling reveal extracellular matrix mechanical regulation of lipid metabolism reprograming through YAP/TEAD4/ACADL axis in hepatocellular carcinoma.
Journal: International journal of biological sciences
Published: December 27, 2022
UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeostasis by targeting PGC1β in hepatocellular carcinoma.
Journal: Signal transduction and targeted therapy
Published: May 10, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026